Key Expert – Cancer Treatment Protocols Expert (Cat. II)
Project: Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.
Indicative Start Date: 9 December 2026
Implementation Period: 14 months (indicative end date: 9 February 2028)
NTU International is currently identifying qualified experts for the EU-funded project “Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.”
The assignment aims to support the institutional strengthening and governance capacities of the Syrian Ministry of Health, contributing to more effective institutional performance, evidence-based decision-making, accountability and sustainable capacity development.
In this context, we are seeking a highly qualified Key Expert – Cancer Treatment Protocols Expert (Cat. II) to provide strategic and technical assistance in the development, harmonisation and implementation of evidence-based systemic anti-cancer therapy protocols, with particular emphasis on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance.
Qualifications and Skills Required
- Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology-Oncology or Clinical Pharmacology .
- A Master's degree in Public Health or a related field is considered an asset .
- Strong capacity to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centres .
- Sound understanding of pharmaceutical supply-chain and quality-assurance considerations affecting essential cancer medicines.
- Ability to facilitate consensus-building among clinical stakeholders on standardised, evidence-based treatment pathways.
- Prior experience supporting ministries of health or national cancer-control programmes in post-conflict or early-recovery contexts is strongly preferred.
General Professional Experience
- Minimum 10 years of clinical or technical experience in medical oncology, including substantial direct experience in the development, harmonisation or revision of national or institutional systemic anti-cancer therapy protocols , particularly chemotherapy protocols .
Specific Professional Experience
- Demonstrated familiarity with current international treatment guidelines (e.g. WHO Essential Medicines List for cancer , NCCN , ESMO ) and their contextual adaptation to resource-constrained or fragile health systems.
- Proven experience developing or strengthening pharmacovigilance and medication-safety systems specific to chemotherapy administration , including adverse-event reporting, dose-verification protocols and safe-handling procedures .
- Experience designing structured clinical training programmes for oncology teams (physicians, pharmacists and nursing staff) on protocol implementation, treatment sequencing and toxicity management .
- Experience developing monitoring and evaluation tools to track treatment adherence ,clinical outcomes and protocol-related safety indicators across multiple oncology centres .
Language Requirements
- English: Excellent written and spoken command – mandatory .
- Arabic: Working knowledge is considered a strong asset .
#J-18808-Ljbffr